Melissa J Schoelwer1, Mark D DeBoer2. 1. Division of Pediatric Endocrinology and Center for Diabetes Technology, University of Virginia, 1215 Lee Street, Charlottesville, VA, 22903, USA. 2. Division of Pediatric Endocrinology and Center for Diabetes Technology, University of Virginia, 1215 Lee Street, Charlottesville, VA, 22903, USA. deboer@virginia.edu.
Abstract
PURPOSE OF REVIEW: Here, we provide a review of recent advancements in closed-loop or automated insulin delivery systems commonly referred to as the "artificial pancreas" (AP) for the management of type 1 diabetes (T1D). RECENT FINDINGS: The use of hybrid closed-loop devices in children and adolescents with T1D consistently increases time in the target glucose range (70-180 mg/dL) without increasing the risk of hypoglycemia. Although hybrid closed-loop systems are able to maintain fairly tight glycemic control overnight, daytime control remains challenging, primarily due to meals and exercise, and careful carbohydrate counting and meal boluses remain essential components of optimal diabetes control. Bihormonal and fully automated AP systems remain investigational at this time. While commercially available hybrid closed-loop AP systems improve glycemic control in children with T1D, more work is needed to achieve a fully automated AP system and decrease the burden of using diabetes technology.
PURPOSE OF REVIEW: Here, we provide a review of recent advancements in closed-loop or automated insulin delivery systems commonly referred to as the "artificial pancreas" (AP) for the management of type 1 diabetes (T1D). RECENT FINDINGS: The use of hybrid closed-loop devices in children and adolescents with T1D consistently increases time in the target glucose range (70-180 mg/dL) without increasing the risk of hypoglycemia. Although hybrid closed-loop systems are able to maintain fairly tight glycemic control overnight, daytime control remains challenging, primarily due to meals and exercise, and careful carbohydrate counting and meal boluses remain essential components of optimal diabetes control. Bihormonal and fully automated AP systems remain investigational at this time. While commercially available hybrid closed-loop AP systems improve glycemic control in children with T1D, more work is needed to achieve a fully automated AP system and decrease the burden of using diabetes technology.
Authors: Michelle A Van Name; Marisa E Hilliard; Claire T Boyle; Kellee M Miller; Daniel J DeSalvo; Barbara J Anderson; Lori M Laffel; Stephanie E Woerner; Linda A DiMeglio; William V Tamborlane Journal: Pediatr Diabetes Date: 2017-04-21 Impact factor: 4.866
Authors: Martin Tauschmann; Julia M Hermann; Clemens Freiberg; Matthias Papsch; Angelika Thon; Bettina Heidtmann; Kerstin Placzeck; Dirk Agena; Thomas M Kapellen; Bernd Schenk; Johannes Wolf; Thomas Danne; Birgit Rami-Merhar; Reinhard W Holl Journal: Diabetes Care Date: 2020-01-22 Impact factor: 19.112
Authors: Nicole C Foster; Roy W Beck; Kellee M Miller; Mark A Clements; Michael R Rickels; Linda A DiMeglio; David M Maahs; William V Tamborlane; Richard Bergenstal; Elizabeth Smith; Beth A Olson; Satish K Garg Journal: Diabetes Technol Ther Date: 2019-01-18 Impact factor: 6.118
Authors: Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Marco Infante; David A Baidal; Michael R Rickels; Andrea Fabbri; Jay S Skyler; Rodolfo Alejandro; Camillo Ricordi Journal: Artif Organs Date: 2021-07-15 Impact factor: 2.663